What Happened?
South San Francisco, CA-based Vera-Therapeutics Appointed Sean Grant as Chief Financial Officer
About the Company
Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera`s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.
About the Person
Sean Grant is Chief Financial Officer at Vera Therapeutics. Previously, Sean held various senior HR leadership roles in the industry.
Info Source
News
Short Profile